Journals / Çocuk Dergisi / 2006 / Cilt: 6 - Sayı: 2

Systemic candida infections in newborn

Yenidoğanda sistemik kandida infeksiyonları

Pages
134–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report we analyzed 25 patient with systemic fungal infection between January 2003-January 2005; with clinical picture, risk factors and therapy used.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic fungal infections are an increasing cause of nosocomial infections in neonatal intensive care units especially among low birth weight infants.
📊
Key Findings & Data:Endotracheal intubation, presence of a central line, parenteral nutrition, prior antibiotic exposure are common risk factors.
💡
Conclusion & Impact:In this report we analyzed 25 patient with systemic fungal infection between January 2003-January 2005; with clinical picture, risk factors and therapy used.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Candida · Kandidiyaz · Süt çocuğu

Abstract

Systemic fungal infections are an increasing cause of nosocomial infections in neonatal intensive care units especially among low birth weight infants. Endotracheal intubation, presence of a central line, parenteral nutrition, prior antibiotic exposure are common risk factors. In this report we analyzed 25 patient with systemic fungal infection between January 2003-January 2005; with clinical picture, risk factors and therapy used.

Özet

Yenidoğan yoğun bakım ünitelerinde (YYBÜ) sistemik kandida infeksiyonları özellikle düşük doğum ağırlıklı bebeklerde nozokomial infeksiyonlar arasında önemli yer tutmaktadır. Endotrakeal entübasyon, santral kateter uygulamaları, parenteral nutrisyon, geniş spektrumlu antibiyotik kullanımı gibi faktörler sistemik kandida infeksiyonlarının gelişmesine yol açmaktadır. Bu çalışmada kliniğimiz YYBÜ'de Ocak 2003-Ocak 2005 tarihleri arasında izlenen 25 sistemik kandida infeksiyonlu vaka klinik özellikler risk faktörleri ve uygulanan tedavi yönünden retrospektif olarak değerlendirilmiştir.

🔖

Cite This Article

ÖZDOĞAN, T., ÖZLÜ, S. G., DEMİR, S., ERGÜVEN, M., ETİ, N., YILDIZ, E., İŞCAN, M. (2006). Systemic candida infections in newborn. Çocuk Dergisi, Cilt: 6 - Sayı: 2, 134–137. https://ajindex.com/articles/160115

References (1)

  1. Chapman L. Rachel; Candida infections in the neonate; Curr Op Pediatr 2003; 15:97-102. 2.Leibovitz Eugene. Neonatal candidosisrclinical picture, management controversies and consensus, and new therapeutic options; J Antimicrob Chemother 2002; 49(SuppI. SI): 69-73. 3.Candida Infection. Department of Neonatal Medicine Protocol Book; Royal Prince Alfred Hospital. 4.National Committee for Clinical Laboratory Standarts 1999. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standart M27-A. National Committee for Clinical Laboratory Standarts; Wayne. Pa. 5.Wisse ME, Aronoff SC. Mycotic infections. In: Behrman RE, Kliegman RM, Jenson HB (eds), Nelson Textbook of Pediatrics WB Saunders Company: Philadelphia, 2004; 1011-4. 6.Benjamin DK, et al. Neonatal candidemia and end-organ damage: A critical appraisal of the literatüre using meta-analytic techniques; Pediatrics 2003; 112: 634-9. 7.Saiman L, et al. Risk factors for candidemia in neonatal intensive care unit patients; Pediatr Infect Dis J 2000; 19:319-24. 8.Luis Ostrosky-Zeichner, et al. Amphotercin B: Time for a new "Gold Standard" Clinic Infect Dis 2003; 37:415-25. 9.Scarcella Alda, et al. Liposomal amphotericin B treatment for neonatal fungal infections; Pediatr Infect Dis J 1998; 17:146-8. 10.Odio CM, et al. Caspofungin therapy of neonates with invasive candidiasis; Pediatr Infect Dis J 2004; 23:1093-7.